Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PFE Pfizer > Detailed Quotes

PFE Pfizer

Watchlist
52.310
-0.120-0.23%
Close 07/01 16:00 ET
52.280
-0.03-0.06%
Post Mkt Price 07/01 19:58 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
52.370
Open
52.040
Turnover
838.62M
Low
51.250
Pre Close
52.430
Volume
16.14M
Market Cap
293.51B
P/E(TTM)
12.00
52wk High
60.749
Shares
5.61B
P/E(Static)
13.59
52wk Low
37.648
Float Cap
292.47B
Bid/Ask %
-33.33%
Historical High
60.749
Shs Float
5.59B
Volume Ratio
0.77
Historical Low
6.081
Dividend TTM
1.57
Div Yield TTM
--
P/B
3.56
Dividend LFY
3.00%
Div Yield LFY
--
Turnover Ratio
0.29%
Amplitude
2.14%
Avg Price
51.948
Lot Size
1
Float Cap
292.47B
Bid/Ask %
-33.33%
Historical High
60.749
Shs Float
5.59B
Volume Ratio
0.77
Historical Low
6.081
Dividend TTM
1.57
P/B
3.56
Dividend LFY
3.00%
Turnover Ratio
0.29%
Amplitude
2.14%
Avg Price
51.948
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
CEO: Bourla D.V.M., DVM, Ph.D., Albert
Market: NYSE
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top